Abnormal post-heparin lipolytic activity in obesity. A preliminary note

Area of Science:

• Biochemistry
• Metabolic Disorders
• Obesity Research

Background:

• Hypertriglyceridemia in obesity is linked to increased triglyceride-rich lipoprotein production and decreased removal.
• Diminished lipoprotein catabolism may stem from reduced tissue lipoprotein lipase activity, observed in obese adipose tissue.
• Heparin-released triglyceride lipase activity (PHLA) abnormalities in obesity remain unreported.

Purpose of the Study:

• To investigate potential defects in PHLA in obese individuals.
• To explore if standard PHLA assays mask underlying issues due to altered plasma volume in obesity.
• To determine if obese individuals exhibit heparin insensitivity or reduced PHLA availability.

Main Methods:

• Standard PHLA assays were conducted in lean and obese volunteers.
• Plasma heparin levels were measured in both groups.
• Pharmacokinetic studies were performed to assess PHLA release dynamics.

Main Results:

• Obese individuals exhibited higher plasma heparin levels compared to lean individuals.
• PHLA values were comparable between obese and lean groups.
• Obese individuals showed an apparent inappropriate PHLA response relative to their elevated heparin levels.

Conclusions:

• Obesity may be associated with an impaired capacity to release PHLA in response to heparin.
• The findings suggest a reduced availability of PHLA for release, rather than heparin insensitivity, contributes to hypertriglyceridemia in obesity.